Press "Enter" to skip to content

Pfizer/BioNTech submit initial data on Covid-19 vaccine for people ages 5 to 11 to FDA

Pfizer and BioNTech said Tuesday they have submitted Covid-19 vaccine data on children ages 5 to 11 to the US Food and Drug Administration for initial review, but are not yet seeking emergency use authorization.

Pfizer and BioNTech said Tuesday they have submitted Covid-19 vaccine data on children ages 5 to 11 to the US Food and Drug Administration for initial review, but are not yet seeking emergency use authorization.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *